Abstract:Background: Conventional approaches to drug discovery are often characterized by lengthy and costly processes. To expedite the discovery of new drugs, the integration of artificial intelligence (AI) in predicting drug-target binding affinity (DTA) has emerged as a crucial approach. Despite the proliferation of deep learning methods for DTA prediction, many of these methods primarily concentrate on the amino acid sequence of proteins. Yet, the interactions between drug compounds and targets occur within distinct segments within the protein structures, whereas the primary sequence primarily captures global protein features. Consequently, it falls short of fully elucidating the intricate relationship between drugs and their respective targets. Objective: This study aims to employ advanced deep-learning techniques to forecast DTA while incorporating information about the secondary structure of proteins. Methods: In our research, both the primary sequence of protein and the secondary structure of protein were leveraged for protein representation. While the primary sequence played the role of the overarching feature, the secondary structure was employed as the localized feature. Convolutional neural networks and graph neural networks were utilized to independently model the intricate features of target proteins and drug compounds. This approach enhanced our ability to capture drugtarget interactions more effectively Results: We have introduced a novel method for predicting DTA. In comparison to DeepDTA, our approach demonstrates significant enhancements, achieving a 3.9% increase in the Concordance Index (CI) and a remarkable 34% reduction in Mean Squared Error (MSE) when evaluated on the KIBA dataset. Conclusion: In conclusion, our results unequivocally demonstrate that augmenting DTA prediction with the inclusion of the protein's secondary structure as a localized feature yields significantly improved accuracy compared to relying solely on the primary structure.

Drug-target binding affinity prediction using message passing neural network and self supervised learning

SubMDTA: drug target affinity prediction based on substructure extraction and multi-scale features

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

Associative Learning Mechanism for Drug-Target Interaction Prediction

GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

A comprehensive review of the recent advances on predicting drug-target affinity based on deep learning

ImageDTA: A Simple Model for Drug-Target Binding Affinity Prediction

GeneralizedDTA: combining pre-training and multi-task learning to predict drug-target binding affinity for unknown drug discovery

Prediction of Drug-Target Affinity Using Attention Neural Network

Enhancing Drug-Target Binding Affinity Prediction through Deep Learning and Protein Secondary Structure Integration

Drug–target affinity prediction with extended graph learning-convolutional networks

Drug–target binding affinity prediction based on three-branched multiscale convolutional neural networks

AttentionDTA: prediction of drug–target binding affinity using attention model

Breaking the barriers of data scarcity in drug–target affinity prediction

Predicting Drug-Target Affinity by Learning Protein Knowledge From Biological Networks

DataDTA: a multi-feature and dual-interaction aggregation framework for drug–target binding affinity prediction

GLSTM-DTA: Application of Prediction Improvement Model Based on GNN and LSTM

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks